Skip to Content

GelStat Corp GSAC

Morningstar Rating
$0.00 0.00 (10.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GSAC is trading at a 33% discount.
Price
$0.00
Fair Value
$1.96
Uncertainty
Extreme
1-Star Price
$3.53
5-Star Price
$9.35
Economic Moat
Lztk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GSAC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$57,351.19
Volume/Avg
194,069 / 3.0 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

GelStat Corp is a consumer healthcare company operating in the US. It is engaged in the development and marketing of over-the-counter (OTC) and other non-prescription consumer healthcare products. The company's lead product is Gelstat Migraine, which is a patented OTC homeopathic drug for use as a first-line, acute treatment for migraine and migraine-like headaches. The Gelstat Migraine is developed to provide acute relief from headache pain as well as other symptoms associated with a migraine. The other products of the company include CHEWS 2 LOSE, which is a diet aide in the form of an all-natural appetite suppressant gum; All Natural Speed which targets specific quick-fix energy user groups; and GelStat Sleep, which provides relief from sleep disorders and their associated symptoms.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
GSAC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
GSAC
Quick Ratio
0.00
Current Ratio
0.01
Interest Coverage
−9.23
Quick Ratio
No chart available

Profitability

Metric
GSAC
Return on Assets (Normalized)
−479.03%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AFkgxhcjcwQnjr$74.6 Bil
MKKGY
Merck KGaA ADRZwtsrbsrkYzqnbt$70.9 Bil
HLN
Haleon PLC ADRYjjjknvRgbs$37.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRXvbhzlzrWztjy$14.9 Bil
VTRS
Viatris IncPrkmrjdhFwzw$13.9 Bil
RDY
Dr Reddy's Laboratories Ltd ADRQqmltbznGdfw$12.2 Bil
CTLT
Catalent IncXlwgmhjRkjms$10.3 Bil
PRGO
Perrigo Co PLCSbddytlcWvtgx$4.3 Bil
CURLF
Curaleaf Holdings IncXspqzhxYqv$3.9 Bil
PBH
Prestige Consumer Healthcare IncQdpyhgdqPlrbdc$3.4 Bil

Sponsor Center